T0	Outcomes 873 902	safety and efficacy of LX4211
T1	Outcomes 965 981	glycemic control
T2	Outcomes 1046 1069	glycated hemoglobin A1c
T3	Outcomes 1128 1350	proportion of subjects achieving a glycated hemoglobin A1c value of <7%, change from baseline in fasting plasma glucose and postprandial glucose (as part of an oral glucose tolerance test), body weight, and blood pressure.
T4	Outcomes 1351 1357	Safety
T5	Outcomes 1396 1471	hypoglycemia, GI symptoms, and incidence of genitourinary tract infections.